ASCO Lung Cancer Highlights, Part 9: The MADeIT Study of Predictive Biomarkers for Chemotherapy in Advanced NSCLC (audio)
- Author
- cancerGRACE - H. Jack West, MD
- Published
- Fri 23 Aug 2013
- Episode Link
- http://cancergrace.libsyn.com/asco-lung-cancer-highlights-part-9-the-ma-de-it-study-of-predictive-biomarkers-for-chemotherapy-in-advanced-nsclc-audio
Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the results and implications of the MADeIT phase III randomized study of preductive biomarkers ERCC1 and RRM1 in advanced NSCLC.
